Diabetes MILES – The Netherlands: rationale, design and sample characteristics of a national survey examining the psychosocial aspects of living with diabetes in Dutch adults by Nefs, Giesje et al.
	 	
	
 
 
This is the published version:  
 
Nefs,	Giesje,	Bot,	Mariska,	Browne,	Jessica	L.,	Speight,	Jane	and	Pouwer,	Francois	2012,	Diabetes	
MILES	–	The	Netherlands:	rationale,	design	and	sample	characteristics	of	a	national	survey	
examining	the	psychosocial	aspects	of	living	with	diabetes	in	Dutch	adults,	BMC	public	health,	vol.	
12,	no.	925,	pp.	1‐11.	
	
	
Available from Deakin Research Online: 
 
http://hdl.handle.net/10536/DRO/DU:30051843	
	
	
	
Reproduced	with	the	kind	permission	of	the	copyright	owner.		
	
Copyright	:	2012,	BioMed	Central	
Nefs et al. BMC Public Health 2012, 12:925
http://www.biomedcentral.com/1471-2458/12/925STUDY PROTOCOL Open AccessDiabetes MILES – The Netherlands: rationale,
design and sample characteristics of a national
survey examining the psychosocial aspects of
living with diabetes in Dutch adults
Giesje Nefs1, Mariska Bot1,2, Jessica L Browne3,4, Jane Speight3,4,5 and François Pouwer1*Abstract
Background: As the number of people with diabetes is increasing rapidly worldwide, a more thorough
understanding of the psychosocial aspects of living with this condition has become an important health care
priority. While our knowledge has grown substantially over the past two decades with respect to the physical,
emotional and social difficulties that people with diabetes may encounter, many important issues remain to be
elucidated. Under the umbrella of the Diabetes MILES (Management and Impact for Long-term Empowerment and
Success) Study International Collaborative, Diabetes MILES – The Netherlands aims to examine how Dutch adults
with diabetes manage their condition and how it affects their lives. Topics of special interest in Diabetes MILES -
The Netherlands include subtypes of depression, Type D personality, mindfulness, sleep and sexual functioning.
Methods/design: Diabetes MILES – The Netherlands was designed as a national online observational study among
adults with diabetes. In addition to a main set of self-report measures, the survey consisted of five complementary
modules to which participants were allocated randomly. From September to October 2011, a total of 3,960
individuals with diabetes (40% type 1, 53% type 2) completed the battery of questionnaires covering a broad range
of topics, including general health, self-management, emotional well-being and contact with health care providers.
People with self-reported type 1 diabetes (specifically those on insulin pump therapy) were over-represented, as
were those using insulin among respondents with self-reported type 2 diabetes. People from ethnic minorities
were under-represented. The sex distribution was fairly equal in the total sample, participants spanned a broad
age range (19–90 years), and diabetes duration ranged from recent diagnosis to living with the condition for over
fifty years.
Discussion: The Diabetes MILES Study enables detailed investigation of the psychosocial aspects of living with
diabetes and an opportunity to put these findings in an international context. With several papers planned resulting
from a pooled Australian-Dutch dataset and data collections planned in other countries, the Diabetes MILES Study
International Collaborative will contribute substantially to identifying potentially unmet needs of those living with
diabetes and to inform clinical research and care across the globe.
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Diabetes mellitus is affecting a growing number of people
worldwide. Global prevalence estimates of this chronic
metabolic condition are projected to rise from 171 mil-
lion in 2000 to 366 million in 2030 [1]. Given the asso-
ciated increased risk of disability [2,3] and mortality [4],
diabetes is considered one of the main threats to human
health of the 21st century [5]. In The Netherlands, the
scope of the problem is similar to these global trends,
with approximately 750,000 people having a diagnosis of
diabetes [6]. In high-income countries, type 2 diabetes
accounts for about 85 to 95% of all diabetes cases [7].
Although less prevalent, type 1 diabetes represents a high
burden of co-morbidities and costs, as people with type 1
diabetes generally live with their condition for a longer
period of time, and may develop complications at an
earlier stage of life [8,9].
Living with diabetes
Leading a fulfilling and enjoyable life while having dia-
betes is certainly possible for many people but, for
others, coping with the condition, its management and
its complications can be both demanding and challen-
ging. Diabetes can be accompanied by distressing acute
short-term complications, such as hypoglycaemia and
ketoacidosis, and by long-term micro-vascular complica-
tions (e.g. retinopathy, neuropathy and nephropathy)
and macro-vascular disease (e.g. stroke, heart disease)
[10]. From previous ground-breaking studies, we know
that these vascular conditions can be prevented or
delayed through optimal management of blood glucose
levels and other cardiovascular risk factors [11-13]. The
importance of daily self-management is therefore un-
questionable but can place a heavy burden on indivi-
duals. Self-management encompasses a wide range of
activities, including daily oral medication and/or insulin
use, blood glucose monitoring, foot care, healthy eating
(and, for some, carbohydrate counting), and engaging in
regular physical activity. Unsurprisingly, diabetes can
have a serious impact on the emotional well-being and
quality of life of people living with the condition [14-17].
In turn, emotional distress may hamper self-care beha-
viours and increase the risk of adverse diabetes out-
comes [18,19]. While our understanding of the
psychosocial aspects of diabetes has increased enor-
mously in the past twenty years [20-24], many important
issues remain to be elucidated.
The Diabetes MILES Study International Collaborative
The Diabetes MILES (Management and Impact for
Long-term Empowerment and Success) Study has been
established as an international collaborative, involving a
series of national surveys and cohort studies among
people with diabetes in various countries [25]. Followingthe example of the original Diabetes MILES – Australia
[25], the general aim of Diabetes MILES – The Netherlands
was to gain greater insights into how people manage their
diabetes and how it impacts on their lives.
In order to enable pooling of data for meaningful
international comparisons and sub-group analyses, the
Australian and Dutch MILES initiatives have both
included a core set of measures focusing on key psycho-
social and behavioural topics (e.g. self-care activities,
symptoms of depression and anxiety, diabetes-related
distress, illness perceptions, perceptions of insulin use)
[25]. An important theme of mutual Australian and
Dutch interest is diabetes self-care.Diabetes self-care
Most existing diabetes self-care questionnaires focus on
the self-reported frequency of common behaviours or
activities necessary for optimal management of diabetes
[26,27]. While this is important, it provides a somewhat
narrow perspective of how people manage their diabetes.
One individual may always take the required number of
insulin injections, eat healthily and be physically active,
yet feel burdened or even burned out by his/her daily
self-care efforts. Another person may decide to monitor
his/her blood glucose levels only occasionally, as he/she
feels that any incremental health benefits do not offset
the loss in quality of life incurred by regular monitoring.
Commonly used self-care inventories do not allow people
with diabetes to indicate how important or how burden-
some it is for them to undertake their daily self-care
tasks. Furthermore, many were designed several years
ago and lack some important dimensions of diabetes self-
care (e.g. the use of cholesterol and blood pressure lower-
ing drugs). A revised version of the Diabetes Self-Care
Inventory [28] assessing the frequency, perceived import-
ance and burden of a wide range of diabetes self-care
activities was included in both the Australian and Dutch
MILES surveys to enable psychometric validation in a
large sample.Additional themes
Although the general survey themes were common be-
tween the Australian and Dutch studies, they differed in
terms of several specific topics of interest, which were
selected purposefully in each country. For Diabetes
MILES – Australia, additional key topics include (1) em-
powerment and self-efficacy, (2) diabetes-specific quality
of life, (3) optimism, (4) role of the family, (5) education
and support programs and (6) hypoglycaemia unaware-
ness. Topics specific to Diabetes MILES – The Netherlands
are discussed below and include (1) subtypes of depression,
(2) Type D personality, (3) mindfulness, (4) sleep and
fatigue and (5) sexual functioning.
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To date, most research examining the general emotional
well-being of people living with diabetes has focused on
depression, with several studies showing that depressed
individuals have higher healthcare use and expenditures,
and are less likely to follow self-care recommendations
[18,29]. In addition, depression in diabetes is associated
with sub-optimal glycaemic control, the development of
micro- and macro-vascular complications, and (all-
cause) mortality [19,30-32]. However, it is unknown
whether individuals experiencing specific symptom clus-
ters or depression subtypes (e.g. somatic versus cognitive
symptoms, melancholic versus atypical symptoms, dys-
phoria versus anhedonia, and depressive symptoms com-
bined with anxiety or manic symptomatology) are
particularly at risk for suboptimal health or self-care ac-
tivities. Preliminary evidence supports the notion that
within the spectrum of depression, symptoms with an
emphasis on reduced positive affect (anhedonia) are
associated with suboptimal glycaemic control, while
symptoms related to negative emotions (dysphoria, anx-
iety) are not [33]. These findings warrant further study.
A focus on the various symptoms and subtypes of de-
pression may add to a better understanding of the rela-
tionship between depression and adverse health
outcomes. This approach is well aligned with current re-
search trends in psychiatry and cardiology [34,35].
Type D “distressed” personality
While depression has been associated with adverse
health outcomes in people with diabetes [19,30-32], less
is known about the risk imposed by other general forms
of psychological distress [36]. In recent years, the Type
D or “distressed” personality has emerged as a risk factor
for adverse psychological and medical outcomes in
people with cardiovascular and non-cardiovascular con-
ditions [36,37]. Individuals with a Type D personality
tend to experience negative emotions across time and
situations (trait Negative Affectivity), but are inclined to
inhibit self-expression in order to avoid disapproval or
rejection by others (trait Social Inhibition) [38]. One po-
tential mechanism through which Type D personality
might exert a negative influence on health includes sub-
optimal self-care behaviour. The studies conducted so
far have involved a variety of populations (healthy young
adults, community samples, and people at high risk of
cardiovascular conditions or those with established car-
diac disease), and indicate that individuals with a Type D
personality are less like to engage in physical activity and
healthy eating, less likely to follow recommended medi-
cation regimens, and are less likely to seek consultations
with health professionals when needed [39-44]. The only
study to date addressing the health risks of Type D per-
sonality in diabetes populations demonstrated thatpeople with type 2 diabetes and Type D personality did
not differ in vascular history or physiological risk factors
compared to their non-Type D counterparts [45]. How-
ever, Type D personality was related to a more sedentary
lifestyle in women [45]. Furthermore, all participants
with Type D personality experienced less social support
and more stressful life events, loneliness, and emotional
distress [45], which may interfere with optimal self-care
[46,47].
Mindfulness
Another topic currently receiving increased research
interest in psychosomatic research is mindfulness, a
state of mind in which an individual intends to maintain
awareness on the present moment in a nonjudgmental
and open manner [48]. The goal of mindfulness inter-
ventions is to develop or increase a greater sense of
emotional balance and well-being by disengaging oneself
from strong attachment to beliefs, thoughts, or emotions
[48]. While preliminary results have shown that
mindfulness-based interventions can reduce emotional
distress, and improve self-care and glycaemic control in
individuals with diabetes [49,50], less is known about the
association between mindfulness as a general personal
attribute and problems with self-management and emo-
tional well-being in people with diabetes.
Sleep
Previous studies have shown that the association be-
tween diabetes and sleep impairment is likely to be bi-
directional [51]. Sleep disorders are a risk factor for the
development of type 2 diabetes, and they exacerbate
metabolic control in both type 1 and type 2 diabetes
[51]. In addition, diabetes itself (especially when accom-
panied by suboptimal glycaemic control and overweight)
is often followed by sleep disturbances [51-53]. Little is
known, however, about the factors associated with sleep
quality and quantity in people with diabetes, or about
the relationship between sleep problems and self-care.
Physical discomfort (including nocturnal hypoglycaemia,
rapid changes in glucose levels, neuropathic pain, sleep
apnoea) are likely to be implicated [51] but there may
also be a link with emotional distress.
Sexual functioning
Sexual problems appear to be a common reality for
people living with diabetes [54]. Until relatively recently,
most studies had focused primarily on sexual difficulties
in men, in particular erectile dysfunction [55]. However,
this does not provide a complete account of sexual func-
tioning in diabetes, as both men and women may face
difficulties with respect to desire, orgasmic capacity or
pain, in addition to arousal-related problems [56,57].
Furthermore, the majority of studies examining the
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do not address the level of intra- or interpersonal con-
cern or distress these dysfunctions may cause [57]. We
currently lack a large scale study that (a) includes both
men and women with type 1 or type 2 diabetes from the
same source population; (b) covers multiple domains of
sexual functioning; (c) incorporates distress in the defin-
ition of sexual dysfunction; while it also (d) examines
both physiological and psychosocial correlates of these
problems.
Research questions
Research questions to be addressed by Diabetes MILES –
The Netherlands include (but are not limited to):
– Is the Diabetes Self-Care Inventory - Revised a valid
self-report measure of the frequency, perceived
importance, and burden of diabetes self-care
activities in people with diabetes?
– Are different subtypes of emotional distress
(melancholic versus atypical depressive symptoms,
mixed depression/anxiety, anhedonia, manic
symptoms) differentially associated with diabetes
self-care activities and healthcare consumption?
– Are people with Type D personality, compared to
those without Type D personality (a) less likely to
engage in adequate self-care activities in terms of
diet, physical activity, medication use, disease
monitoring, smoking and alcohol consumption; and
(b) less likely to attend medical appointments or to
consult their physician or nurse in case of symptoms
or problems with diabetes self-care?
– Is a higher level of mindfulness associated with
greater engagement in self-care activities and better
emotional well-being in people with diabetes?
– Which factors are associated with sleep quality and
quantity in people with diabetes? Is there a
relationship between sleep problems and diabetes
self-care?
– What are the correlates of sexual dysfunction in
people with diabetes?
Methods/design
Study design
Diabetes MILES – The Netherlands was designed as a
national observational study of Dutch people with dia-
betes. Initially developed as an independent research
project, the Dutch initiative was joined with its Austra-
lian counterpart to form The Diabetes MILES Study
International Collaborative during the final stages of its
survey development due to similarities in study design
and goals. As a consequence, there are some differences
between the two surveys in terms of key themes (dis-
cussed above) and procedures. One of these relates tothe mode of data collection. While Diabetes MILES –
Australia included both postal and internet-based
versions [25], the Dutch survey was available online
only. The online survey was created using the web appli-
cation “SpITS Questionnaire”, which was developed by
the local information technology service of the School of
Social and Behavioural Sciences of Tilburg University.
Questions were presented successively, with pre-
programmed skip patterns for items that were not
applicable (e.g. after a participant indicates that they do
not use insulin, the questions relating to insulin use are
skipped). To reduce the number of missing values, most
items had forced choice response formats. Based on pilot
testing, estimated completion time of the survey was
45 min. Participants were offered the possibility of
completing the survey in multiple stages. In order to re-
duce participant burden, the survey consisted of a main
questionnaire (items to be completed by all respondents)
and five complementary modules. Each respondent first
completed the main set of questions and was subse-
quently assigned randomly to one of the complementary
modules by a computer algorithm. The survey was
available for completion online from September 6th to
October 31st 2011.
Participants
In close co-operation with the Dutch Diabetes Associ-
ation (DVN, Diabetes Vereniging Nederland), Dutch
adults with diabetes were invited to participate in the
online survey. Although we tried to reach non-members
of DVN as well, most recruitment efforts focused on
people registered with DVN. While people with self-
reported diabetes of any type were allowed to complete
the survey, the main analyses will focus on those with
type 1 or type 2 diabetes. As individuals aged 18 years
were approached for participation in a parallel Dutch
MILES initiative among children and adolescents with
diabetes, the lower age limit of the adult study was 19
years. No upper age limit was specified.
Procedure
The study was advertised through several media chan-
nels, including Dutch health websites, the monthly
DVN magazine ‘Diabc’, a DVN twitter account and a
digital e-newsletter sent to all subscribed members of
DVN and the Dutch Diabetes Research Foundation
(Diabetesfonds). As an incentive for participation, partici-
pants were invited to enter a draw to win one of two tablet
computers. Interested individuals were invited to visit the
study’s website to find out more about taking part in the
study. In addition to information about the aims, contents
and design of the study, the website contained a page
where people with diabetes aged 19 and older could
register for the study. This page clearly stated that
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publications would be based on anonymous data. Partici-
pants provided an email address so that they could be
sent a personalised link to access the online question-
naire. It was emphasised that this personal information
would be used for this purpose only and, to ensure
anonymity, no other personally identifiable information
(e.g. name, home address) was requested. Digital
informed consent was sought by asking participants to
tick a box in front of a statement specifying that they
had diabetes, were 19 years or older, had read and
understood the study information on the registration
page, and were willing to participate in the survey.
After registration, every participant was assigned a
unique identifier (ID number). This coding was gener-
ated automatically by the software and consisted of
unique successive numbers. The software automatically
checked whether a certain email address was already
registered, thereby minimizing the possibility of someone
registering and completing the survey twice. If partici-
pants had any questions, they were referred to the
Frequently Asked Questions page of the study’s website.
In addition, they could contact a member of the research
team by telephone or email. The online survey responses
were saved on a secure Tilburg University server and
were exported to Microsoft Office Excel and SPSS (Stat-
istical Package for Social Sciences) Version 18 (IBM
SPSS Statistics, NY, USA) files for data cleaning and
analyses.
Measures
Selection of study topics and corresponding assessment
instruments was based on literature review, consultation
with experts in the field, and feedback from people with
diabetes who had participated in previous surveys. For
certain topics, no suitable pre-existing questionnaires
were available, so appropriate study-specific items were
designed by the research team. The main survey
included standardised measures of general health,
healthcare consumption, self-care behaviours and emo-
tional well-being as well as items eliciting demographics
and clinical characteristics. The five additional survey
modules covered a wide range of topics, including (1)
self-care attitudes and beliefs (e.g. psychological insulin
resistance, fear of hypoglycemia); (2) subtypes of depres-
sion; (3) mindfulness and positive mental health; (4)
sleep, fatigue and pain; (5) relationships with others (e.g.
social support, sexual problems). An overview of the
concepts and measures included in Diabetes MILES –
The Netherlands is provided in Table 1.
Ethical principles
The study protocol of Diabetes MILES – The Netherlands
was approved by the Psychological Research EthicsCommittee of Tilburg University, The Netherlands (EC-
2011 5). As the study was internet-based, digital informed
consent was obtained from all participants.
Statistical analyses
Statistical analyses will be performed using the Statistical
Package for Social Sciences (SPSS). Unless otherwise
specified, a significance level of p<0.05 will be adopted
in all statistical analyses. Sample and sub-sample charac-
teristics will be presented using frequencies for categor-
ical variables and mean ± standard deviation for
continuous variables. Depending on the research ques-
tion, differences between subgroups (e.g. men versus
women, type 1 versus type 2 diabetes) will be tested
using chi-squared tests for categorical data, and inde-
pendent samples t-tests/analyses of variance for continu-
ous variables. Multiple linear (continuous dependent
variable) and logistic (binomial dependent variable) re-
gression analyses will be used to study the association
between the independent and dependent variables of
interest. Other analyses may be applied and will be
reported in the papers concerned. We aimed to recruit
at least 3,000 participants in order to ensure that the
study was powered sufficiently to enable various sub-
group analyses.
Sample characteristics
Figure 1 provides an overview of study participation and
drop-out. A total of 4,590 people registered an email ad-
dress on the study website expressing interest in partici-
pation, of whom 86% (n=3,960) accessed the survey via
the personal hyperlink. The latter number, reflecting all
individuals who commenced the online survey (not ne-
cessarily completing it), defines the total Diabetes
MILES – The Netherlands sample. We were not able to
determine the reasons why the remaining 630 did not
open the survey. Of the total sample (n=3,960; 100%),
1,573 (40%) self-reported having type 1 diabetes, 2,108
(53%) type 2 diabetes, and 70 (2%) a different type of
diabetes or a related condition, e.g. LADA (Latent Auto-
immune Diabetes in Adults), MODY (Maturity-Onset
Diabetes of the Young), pre-diabetes, diabetes in remis-
sion. The remaining 5% of participants did not complete
this item or their diagnosis was unclear to them. In total,
3,406 participants (86%) completed the main survey and
were randomised to one of the five complementary
modules (19-21% randomised to each module). The en-
tire survey (i.e. the main survey plus one module) was
completed by 3,332 participants (84%). Table 2 shows
the demographic and clinical characteristics of the total
Diabetes MILES – The Netherlands sample (n=3,960),
and separately for participants with self-reported type 1
and type 2 diabetes. While the total sample showed a
fairly equal sex distribution, women were slightly over-
Table 1 Variables included in Diabetes MILES – The Netherlands (2011)
Concept Measure or variable * Survey version
Demographics Sex†‡, age†‡, marital status†‡, ethnicity†, education†‡, current employment†‡, shift work All participants
Diabetes (clinical) Diabetes type†‡, diabetes duration†‡, current treatment regimen†‡, current blood glucose
level, most recent HbA1c†‡, HbA1c target level, number of severe hypos/hypers in past year,
main diabetes health professional, membership of patient organisation†‡
All participants
General health Height†‡, weight†‡, waist circumference†‡, hip circumference, presence of and medication
for co-morbid conditions (including diabetes complications)†‡, number of hospitalisations in
past year
All participants
Health consultations Number of contacts with health professionals† in past year, cancelled appointments in past
year, consultation behaviour (10 items)
All participants
Self-care behaviours Diabetes Self-Care Inventory Revised (unpublished) plus Diabetes MILES – Australia smoking
items†‡
All participants
Medication taking ASK-12: Adherence Starts with Knowledge 12-item version [61] All participants
Physical Activity IPAQ: International Physical Activity Questionnaire (Short Form)[62], questions about sedentary
behaviour adapted from Diabetes MILES - Australia
All participants
Eating behaviour 38-item food frequency questionnaire All participants
Disordered eating 6 items†‡ plus 2 items with respect to insulin adapted from Diabetes MILES – Australia All participants
Alcohol consumption 1 item: number of units per week All participants
Diabetes-related distress PAID: Problem Areas In Diabetes scale [63]†‡ All participants
Depression PHQ-9: Patient Health Questionnaire 9-item scale [64]†‡ All participants
Anxiety GAD-7: Generalized Anxiety Disorder 7-item scale [65]†‡ All participants
Type D personality DS14: Type D Scale-14 [38] All participants
Stressful life event(s) 1 item: stressful life event(s) in past year All participants
Loneliness 1 item: loneliness in past year All participants
Psychological insulin resistance ITAS: Insulin Treatment Appraisal Scale [66]†‡ Module 1
Fear of hypoglycaemia HFS-II: Hypoglycaemia Fear Survey-II [67] Module 1
Diabetes-specific avoidance 6 items Module 1
Eating style DEBQ: Dutch Eating Behavior Questionnaire [68] Module 1,3
Beliefs about diabetes BIPQ: Brief Illness Perception Questionnaire (diabetes version) [69]†‡ Module 1,3
Anhedonia 4-item anhedonia subscale HADS: Hospital Anxiety and Depression Scale [70] Module 2
Manic symptoms MDQ-NL: Mood Disorder Questionnaire [71] Module 2
Subtypes of depression IDS-SR: Inventory of Depressive Symptomatology – self reported [72] Module 2
Mindfulness FFMQ-NL: Five Facet Mindfulness Questionnaire – Dutch version [73] Module 3
Neuropathic pain NeuroQoL: Neuropathy and foot ulcer-specific Quality of Life questionnaire (physical symptom
measures only) [74]
Module 3,4
Positive mental health MHC-SF: Mental Health Continuum - Short Form (emotional and psychological subscales only) [75] Module 3
Sleep PSQI: Pittsburgh Sleep Quality Index [76] Module 4
Fatigue FAS: Fatigue Assessment Scale [77] Module 4
Daytime sleepiness ESS: Epworth Sleepiness Scale [78] Module 4
Social support MSPSS: Multidimensional Scale of Perceived Social Support [79] Module 5
Relationship adjustment DAS: Dyadic Adjustment Scale [80] Module 5
Sexual problems SSFS: Short Sexual Functioning Scale – male and female version (Enzlin et al., unpublished) Module 5
* Unless otherwise specified, the question(s) was/were designed by the Diabetes MILES – The Netherlands research team.
† Diabetes MILES Study core measures, to be included in all surveys of adults living with type 1 or type 2 diabetes.
‡ Measures present in the pooled Australian-Dutch data-set.
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with type 1 diabetes were younger, more likely to have a
higher educational level and paid employment, and had
lived for longer with their condition than those with type
2 diabetes. They had a lower mean body mass index, buta somewhat less optimal mean HbA1c. Compared to the
national diabetes population distribution [58], those with
self-reported type 1 diabetes, type 1 diabetes on insulin
pump therapy, and type 2 diabetes using insulin were
over-represented.
Registered for participation
n = 4,590
Opened survey web application
n = 3,960
Self-reported type of diabetes:
- Type 1 (n = 1,573)
- Type 2 (n = 2,108)
- LADA (n = 37)
- MODY (n = 14) 
- Other (type 1 and 2, type 3, secondary diabetes, MIDD) (n = 16)
- Related condition (at risk/IGT, diabetes in remission) (n = 3)
- Unclear, does not know, missing (n = 209)
Completed main questionnaire &
randomized to
complementary modules
n = 3,406
Type 1 n = 1,417
Type 2 n = 1,884
1) Self-care
n = 687
Type 1 n = 291
Type 2 n = 375
2) Subtypes depression
n = 714
Type 1 n = 292
Type 2 n = 398
3) Mindfulness
n = 684
Type 1 n = 299
Type 2 n = 367
4) Sleep, fatigue & pain
n = 679
Type 1 n = 284
Type 2 n = 374
5) Relation with others
n = 642
Type 1 n = 251
Type 2 n = 370
Completed entire survey
n = 3,332
Type 1 n = 1,383
Type 2 n = 1,845
Figure 1 Flow chart of Diabetes MILES – The Netherlands.
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Diabetes is a common long-term condition, and as the
prevalence for all types of diabetes is likely to continue
to increase during the next two decades [1,5,59], it has
never been more vital to further our understanding of
the everyday experiences, well-being, self-care activities,
and health beliefs of people living with this condition. By
examining the way people manage their diabetes, and
the physical, emotional and social difficulties they en-
counter, unmet needs can potentially be identified and
used to inform care provision. The results of Diabetes
MILES – The Netherlands may provide insights
into which subgroups of people are at high risk of pro-
blems with self-management and emotional well-being,
and could guide the development of future intervention
studies.
Strengths and limitations
The major strengths of Diabetes MILES – The
Netherlands include the relatively large sample size
(n=3,960) and the wealth of detailed data captured
regarding well-being, self-care and health. The present
Diabetes MILES – The Netherlands study may serve as
the baseline assessment of a potential longitudinal co-
hort study examining prospective associations between
emotional well-being and other health outcomes. Under
the umbrella of The Diabetes MILES Study International
Collaborative, analysis of the pooled Dutch andAustralian Diabetes MILES datasets is currently under-
way. This pooled dataset has a total participant sample
of 7,019, which is large enough to permit sub-group ana-
lyses of rare groups within the sample, and thorough
examination of less common characteristics.
The limitations of Diabetes MILES – The Netherlands
are those inherent to any internet-based self-report sur-
vey. By advertising the study in relevant health media ra-
ther than contacting a pre-determined random sample,
those who are actively engaged in their diabetes care,
seek out opportunities to increase their knowledge or
communicate with peers, or for whom diabetes is expli-
citly present in their daily lives are likely to be over-
represented. This may be reflected by the fact that the
majority of our sample consisted of those with self-
reported type 1 diabetes or type 2 diabetes using insulin
therapy, while the vast majority of people with diabetes
have type 2 diabetes managed with a combination of life-
style modifications and blood glucose lowering tablets.
Furthermore, over 90% indicated that they were mem-
bers of DVN. This is unsurprising given DVN’s promin-
ent role in advertising for the study. With respect to
prevalence estimates, however, this may limit the gener-
alisability of our findings to the general Dutch diabetes
population.
While the decision to offer the survey for online
completion only may have introduced some bias
into the sample, the impact of this is unlikely to be
Table 2 Sample characteristics of Diabetes MILES – The Netherlands (2011)
All Type 1 diabetes Type 2 diabetes
(n=3,960) (n=1,573) (n=2,108)
Demographics
Women 54% (2,133/3,925) 61% (958/1,572) 48% (1,020/2,108) ‡
Age in years 55 ± 14 47 ± 15 62 ± 10 ‡
Ethnic minority 3% (104/3,884) 2% (34/1,573) 3% (58/2,108)
Educational level
Low 27% (1,040/3,870) 19% (293/1,571) 33% (684/2,101)
Middle 34% (1,313/3,870) 35% (546/1,571) 34% (704/2,101)
High 39% (1,517/3,870) 47% (732/1,571) 34% (713/2,101) ‡
Having a partner 80% (3,107/3,889) 80% (1,260/1,573) 80% (1,682/2,108)
Paid employment 48% (1,838/3,873) 63% (992/1,571) 36% (763/2,104) ‡
Clinical characteristics
Duration of diabetes in years 16 ± 13 23 ± 15 11 ± 8 ‡
Diabetes treatment
Insulin pump 24% (910/3,786) 48% (761/1,572) 6% (125/2,102) ‡
Insulin injections 50% (1,891/3,786) 53% (830/1,572) 47% (995/2,102) †
Glucagon-like peptide-1 (GLP-1) agonist injections 2% (62/3,786) 0.1% (2/1,572) 3% (59/2,102) ‡
Blood glucose lowering tablets 44% (1,627/3,664) 7% (111/1,566) 74% (1,474/1,987) ‡
Lifestyle only 3% (99/3,726) 0% (0/1,572) 5% (95/2,042) ‡
Most recent HbA1c (mmol/mol) 56 ± 12 58 ± 12 54 ± 12 ‡
Body Mass Index (kg/m2) 28 ± 6 25 ± 5 30 ± 6 ‡
Macro-vascular disease and/or micro-vascular complications *
None 69% (2,544/3,691) 70% (1,077/1,539) 68% (1,383/2,041)
One 20% (729/3,691) 18% (276/1,539) 21% (436/2,041)
Two or more 11% (418/3,691) 12% (186/1,539) 11% (222/2,041) †
Values are mean ± standard deviation, unless otherwise specified.
* Self-reported myocardial infarction, stroke, peripheral arterial disease, nephropathy, retinopathy, neuropathy and/or foot condition.
† Difference between self-reported type 1 and type 2 diabetes p < 0.05.
‡ Difference between self-reported type 1 and type 2 diabetes p < 0.001.
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Bureau of Statistics show that The Netherlands is
among the countries with the highest internet coverage
rate in Europe, with over 90% of the Dutch population
having access to the internet [60]. The main reasons
for not having internet access include lack of interest
(3%) and insufficient knowledge/physical disabilities
(1%) [60]. With 56% of participants in the present
study aged between 50 and 70 years, 12% aged over 70
years, and an overall age range spanning 19 to 90
years, older adults did not appear to be deterred from
participating in an online study. However, as 69% of
the total sample did not report having micro-vascular
complications or macro-vascular disease (Table 2),
those in relatively good health may have been some-
what over-represented.
As all clinical variables were determined through self-
report, we cannot rule out a certain margin of error in
these measures. For example, some people with type 2
diabetes using insulin treatment may have self-identifiedas having type 1 diabetes, while for self-reported compli-
cations or co-morbidities, some people may not
be aware of specific diagnoses. For measures susceptible
to bias through social desirability (e.g. most recent
HbA1c, weight, waist-hip measurements), we hope that
our procedures to ensure anonymity minimised some of
these effects.
Although people with self-reported diabetes of any
type were invited to complete the survey, only a small
minority (n=70) indicated having a type of diabetes other
than type 1 or type 2, or a condition closely related to,
but not actually, diabetes. While this limits the oppor-
tunity to compare outcomes across less common dia-
betes types (e.g. MODY, LADA, secondary), these
findings inform us about which individuals self-identify
with a study focusing on “living with diabetes”. We
recommend that future research efforts target these
minority types of diabetes to ensure greater understand-
ing of the specific well-being and self-care needs of these
groups.
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http://www.biomedcentral.com/1471-2458/12/925By definition, we were unable to include people with
type 2 diabetes who are unaware of their condition (that
is, those with undiagnosed type 2 diabetes). Epidemio-
logical studies have shown that up to 50% of all Dutch
people with diabetes are undiagnosed [59], though more
recent estimates suggest that the number of Dutch
people with undiagnosed type 2 diabetes has decreased
to approximately one quarter of the total diabetes popu-
lation, possibly due to improvements in screening and
early diagnosis [6].
People from ethnic minority backgrounds were under-
represented in our sample. Due to practical considera-
tions, the Diabetes MILES – The Netherlands survey
was available only in Dutch. Knowing that ethnic minor-
ities represent a vulnerable subgroup in terms of their
health outcomes, future MILES initiatives need to pro-
mote participation of people from culturally and linguis-
tically diverse backgrounds [25].
Although the breadth of the survey enables a thorough
analysis of the psychosocial wellbeing of participants, the
length of the survey (estimated completion time 45 min)
may have caused individuals with mental health co-
morbidities or physical disabilities to leave the study pre-
maturely, or not to enter the study in the first place.
Taking into account that it was impossible to register
for the study twice with the same email address, we may
have systematically excluded participants’ family mem-
bers also diagnosed with diabetes (and thereby eligible)
but using the same email address. It is also possible, al-
though highly unlikely, that individuals may have partici-
pated multiple times using different email addresses.
Conclusions
Diabetes MILES initiatives are currently being planned
in other countries, and this will facilitate further data
pooling as well as provide specific insights into what it is
like to live with diabetes in various countries. Those
interested in joining The Diabetes MILES Study Inter-
national Collaborative are invited to contact Professor
Jane Speight or Professor François Pouwer. Even though
the main focus of The Diabetes MILES Study is
currently on adults with type 1 or type 2 diabetes,
future research is expected to also include children and
adolescents with diabetes and their parents, and special
subgroups of diabetes (e.g. gestational, MODY, LADA,
secondary), in order to provide a more comprehensive
overview of the psychosocial implications of living with
diabetes.
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